Roche said it didn’t want to buy Poseida last year: A look at how the $1.5B buyout came to be

After receiving an unsolicited acquisition proposal from an unnamed Big Pharma in 2023, Poseida reached out to inform partner Roche of the offer, at which point the Swiss pharma said it wasn’t interested in buying the biotech at the time.